A Pediatric Sepsis Protocol Reduced Mortality and Dysfunctions in a Brazilian Public Hospital

Daniela Nasu Monteiro Medeiros1, Ana Carolina Cintra Nunes Mafra2, Joseph Anthony Carcillo3

  • 1Department of Pediatric Intensive Care Unit, Hospital Israelita Albert Einstein, São Paulo, Brazil.

Frontiers in Pediatrics
|December 6, 2021
PubMed

Insights

Implementing a simple sepsis bundle protocol in a low-income country hospital significantly reduced in-hospital mortality for sepsis and severe sepsis. This low-cost intervention also decreased organ dysfunction and the likelihood of developing septic shock.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Global Health

Background:

  • Sepsis management in low- and middle-income countries faces resource limitations and high mortality rates.
  • Few studies evaluate the impact of sepsis bundles in these resource-constrained settings.
  • Sepsis bundles aim to standardize care and improve outcomes for critically ill patients.

Purpose of the Study:

  • To assess the association between sepsis bundle compliance and in-hospital mortality in a low-income country.
  • To evaluate the bundle's effect on preventing septic shock and organ dysfunction.
  • To determine the feasibility and impact of a low-cost sepsis protocol in Brazil.

Main Methods:

  • Retrospective cohort study at a public hospital in a low-income region of Brazil.
  • Evaluated 548 children with sepsis, severe sepsis, or septic shock (2008-2016).
  • Bundle compliance included timely diagnostics, antibiotics, and fluid resuscitation.

Main Results:

  • Protocol group showed significantly lower median length of stay (3 vs. 11 days).
  • Fewer organ dysfunctions (0 vs. 2) and reduced progression to septic shock observed.
  • Propensity score analysis revealed significantly lower mortality (2.75% vs. 15.4%) post-protocol implementation.

Conclusions:

  • A simple, low-cost sepsis bundle protocol is feasible and effective in resource-limited settings.
  • Protocol implementation led to decreased mortality and progression of organ dysfunction.
  • Sepsis bundle compliance is associated with a reduced probability of developing septic shock.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
19
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
20
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
27